Skip to main content
Clinical Trials/NL-OMON36448
NL-OMON36448
Recruiting
N/A

ong-term effects of psychotropic medication on the developing brain. A cohort study based on medical prescription data - ePOD-IPCI

Radiologie, Div I0 sites150 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
bijwerkingen van medicijnen
Sponsor
Radiologie, Div I
Enrollment
150
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Radiologie, Div I

Eligibility Criteria

Inclusion Criteria

  • Exposed group: Females aged 23\-30 years who have been treated with fluoxetine or another SSRI before age 16 (preferably at age 12\-14\) or treated at 23\-30 years, presumably for treatment of moderate to severe MDD or anxiety disorder. Males aged 23\-30 years who have been treated with methylphenidate before age 16 (preferably at age 10\-12\) or treated at age 23\-30, presumably for treatment of ADHD.
  • Unexposed groups:
  • There will be two unexposed groups 23\-30 years of age consisting of drugnaive subjects suffering from ADHD or MDD/anxiety disorder.

Exclusion Criteria

  • \-IQ \< 70 (National Adult Reading Test (NART); Nelson, 1991\).
  • \-Alcohol and/or drug dependence according to DSM\-IV criteria.
  • \- Contraindications to MRI scanning (any kind of irremovable metal inside the body (including piercings, (large) tattoo\*s, brackets, etc.), neurological disorders (e.g. epilepsy), claustrophobia).
  • \-In case of female subjects: pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
egative effect of use of psychotropic drugs on psychiatric symptoms, and cognitive and physical function in elderly:prospective observational study among hospitalized patients.Psychiatric symptoms and decline of cognitive and physical function
JPRN-UMIN000004448Ishikawa Prefectural Takamatsu Hospital100
Recruiting
N/A
the study of &quot;the effect of the psychotropic (hypnotic) drugs, antipsychotic drugs, and/or antidepressant drugs on clinical symptoms, sleep quality, cognitive function, daily activity, health related quality of life, and survival in patients with chronic hypercapnic respiratory failure who have received long-term oxygen therapy and/or nocturnal noninvasive positive pressure ventilation for a long time.&quot;patients with chronic hypercapnic respiratory failure receiving a long-term oxygen therapy and/or noninvasive positive pressure ventilation (NPPV)
JPRN-UMIN000010608Department of Respiratory Medicine, Natonal Hospital Orgnization MInami-Kyoto Hospital600
Completed
N/A
the study of &quot;the effect of the psychotropic (hypnotic) drug on sleep quality, cognitive function and daily activity in patients with chronic hypercapnic respiratory failure who have received nocturnal noninvasive positive pressure ventilation for a long time.&quot;patients with chronic hypercapnic respiratory failure receiving a long-term noninvasive positive pressure ventilation (NPPV)
JPRN-UMIN000005989Department of Respiratory Medicine, Natonal Hospital Orgnization MInami-Kyoto Hospital50
Completed
Phase 2
Concomitant psychotropic medication and electroconvulsive therapy on Schizophreniaschizophrenia.Schizophrenia
IRCT201107143930N7Vice chancellor for research, Shiraz University of Medical Sciences60
Recruiting
N/A
The effect of pharmacotherapy and psychosocial therapy on cognitive function and life style
JPRN-UMIN000019297agoya University Graduate School of Medicine100